Adamis Pharmaceuticals Corp. Company Profile (NASDAQ:ADMP)

About Adamis Pharmaceuticals Corp.

Adamis Pharmaceuticals Corp. logoAdamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADMP
  • CUSIP:
Key Metrics:
  • Previous Close: $3.37
  • 50 Day Moving Average: $2.95
  • 200 Day Moving Average: $4.89
  • 52-Week Range: $2.50 - $10.98
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $69.76M
  • Outstanding Shares: 20,886,000
  • Beta: -0.36
Profitability:
  • Return on Equity: -166.69%
  • Return on Assets: -110.18%
Debt:
  • Current Ratio: 0.18%
  • Quick Ratio: 0.09%
Additional Links:
Companies Related to Adamis Pharmaceuticals Corp.:

Analyst Ratings

Consensus Ratings for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (199.40% upside)

Analysts' Ratings History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
Show:
DateFirmActionRatingPrice TargetDetails
9/19/2016Maxim GroupSet Price TargetBuy$10.00View Rating Details
5/29/2015MizuhoInitiated CoverageBuy$10.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
Insider Ownership Percentage: 9.60%
Institutional Ownership Percentage: 9.70%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/2/2016David J MarguglioVPSell700$9.00$6,300.00View SEC Filing  
5/16/2016David J MarguglioSVPSell4,000$8.08$32,320.00View SEC Filing  
5/9/2016David J MarguglioSVPSell4,860$10.00$48,600.00View SEC Filing  
5/4/2016David J MarguglioSVPSell4,860$9.17$44,566.20View SEC Filing  
5/3/2016David J MarguglioSVPSell1,140$9.00$10,260.00View SEC Filing  
4/14/2016David J MarguglioSVPSell12,000$7.52$90,240.00View SEC Filing  
8/14/2015Robert B RothermelDirectorBuy7,000$3.33$23,310.00View SEC Filing  
4/20/2015David J MarguglioSVPSell200$5.00$1,000.00View SEC Filing  
4/14/2015David J MarguglioSVPSell2,200$5.01$11,022.00View SEC Filing  
3/4/2015David J MarguglioSVPSell11,800$7.09$83,662.00View SEC Filing  
3/2/2015David J MarguglioSVPSell7,000$6.45$45,150.00View SEC Filing  
2/13/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell12,076$6.41$77,407.16View SEC Filing  
2/12/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell38,000$6.40$243,200.00View SEC Filing  
2/3/2015Ahmed Shayan Fazlur RahmanMajor ShareholderSell30,000$6.75$202,500.00View SEC Filing  
1/5/2015David J MarguglioVPSell7,000$6.18$43,260.00View SEC Filing  
12/30/2014David J MarguglioSVPSell12,228$6.09$74,468.52View SEC Filing  
12/29/2014David J MarguglioVPSell772$6.00$4,632.00View SEC Filing  
12/12/2014David J MarguglioSVPSell4,000$5.18$20,720.00View SEC Filing  
9/2/2014William C DenbyDirectorBuy2,500$5.06$12,650.00View SEC Filing  
8/29/2014Robert B RothermelDirectorBuy5,500$4.03$22,165.00View SEC Filing  
6/2/2014David J MarguglioSVPSell4,000$5.56$22,240.00View SEC Filing  
8/14/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell7,015$0.57$3,998.55View SEC Filing  
8/7/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell40,000$0.56$22,400.00View SEC Filing  
8/2/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell67,960$0.57$38,737.20View SEC Filing  
7/30/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell10,328$0.56$5,783.68View SEC Filing  
7/26/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell95,000$0.56$53,200.00View SEC Filing  
7/23/2013Ahmed Shayan Fazlur RahmanMajor ShareholderSell141,224$0.57$80,497.68View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Adamis Pharmaceuticals Corp. (NASDAQ:ADMP)
DateHeadline
biz.yahoo.com logoADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:ADMP)
biz.yahoo.com - September 24 at 8:31 AM
News IconMy Watchlist for Wednesday, September 21 (NASDAQ:ADMP)
ac-investor.blogspot.com - September 21 at 10:50 AM
News IconStock Update, a Closer Look at Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Duncan Research (NASDAQ:ADMP)
www.duncanindependent.com - September 15 at 3:18 PM
News IconKeen Investors Narrowing Their Focus on Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Duncan Research (NASDAQ:ADMP)
www.duncanindependent.com - September 14 at 8:35 PM
thestreet.com logoRelief From EpiPen's Stranglehold May Come From Rivals Before Politicians (NASDAQ:ADMP)
realmoney.thestreet.com - September 13 at 8:07 AM
News IconHere's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Slumping Today (NASDAQ:ADMP)
www.topix.com - September 1 at 11:45 AM
marketwatch.com logoMylan’s EpiPen caught the full force of drug price outrage because it was the perfect target, not because it was the only one (NASDAQ:ADMP)
www.marketwatch.com - August 31 at 3:18 PM
News IconAntares Pharma Inc (NASDAQ:ATRS) Might Have The Edge Over Adamis Pharmaceuticals Corp (NASDAQ:ADMP) In ... - Street Register (NASDAQ:ADMP)
streetregister.com - August 31 at 8:04 AM
News IconCerus Corporation (NASDAQ:CERS) & Adamis Pharmaceuticals ... - Money News (NASDAQ:ADMP)
www.newsismoney.com - August 31 at 8:04 AM
News IconStocks in the Spotlight: Adamis Pharmaceuticals Corp (NASDAQ:ADMP), Net 1 UEPS Technologies Inc (NASDAQ ... - NYSE Journal (press release) (NASDAQ:ADMP)
stockznews.com - August 30 at 12:19 PM
wsj.com logo[$$] Mylan’s New Generic Causes Stock-Market Ripple (NASDAQ:ADMP)
www.wsj.com - August 29 at 8:52 PM
News IconStock Gapping Lower Before the Bell: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Post News (NASDAQ:ADMP)
www.kentuckypostnews.com - August 29 at 3:46 PM
News IconStock Heading Down in Trade: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Post News (NASDAQ:ADMP)
www.kentuckypostnews.com - August 29 at 3:46 PM
News IconWhy Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Could Benefit From Mylan's Woes - Scibility Media (NASDAQ:ADMP)
scibilitymedia.com - August 29 at 3:46 PM
wsj.com logoMylan's New Generic Causes Stock Market Ripple (NASDAQ:ADMP)
blogs.wsj.com - August 29 at 3:46 PM
News IconAdamis Pharmaceuticals Corp (NASDAQ:ADMP) Looks Primed For Gains On Mylan NV (NASDAQ:MYL) Mess - Street Register (NASDAQ:ADMP)
streetregister.com - August 27 at 3:18 PM
News IconAdamis Pharmaceuticals Corp (NASDAQ:ADMP) Looks Primed For Gains On Mylan NV (NASDAQ:MYL) Mess (NASDAQ:ADMP)
streetregister.com - August 27 at 8:05 AM
thestreet.com logoHere's a Reason Why Adamis Pharmaceuticals (ADMP) Stock Is Soaring Today (NASDAQ:ADMP)
www.thestreet.com - August 26 at 3:18 PM
thestreet.com logoPharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco (NASDAQ:ADMP)
www.thestreet.com - August 26 at 3:18 PM
barrons.com logo[$$] Mylan's EpiPen Fallout Benefits Adamis (NASDAQ:ADMP)
www.barrons.com - August 26 at 11:26 AM
News IconStock Recorded Gapping Up Pre-Bell: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Post News (NASDAQ:ADMP)
www.kentuckypostnews.com - August 24 at 3:20 PM
finance.yahoo.com logoADAMIS PHARMACEUTICALS CORP Financials (NASDAQ:ADMP)
finance.yahoo.com - August 24 at 3:20 PM
live-pr.com logoNew Market Research Report: Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic SWOT Analysis Review (NASDAQ:ADMP)
www.live-pr.com - August 24 at 11:36 AM
News IconMy Watchlist for Wednesday, August 24 (NASDAQ:ADMP)
ac-investor.blogspot.com - August 23 at 8:38 PM
thestreet.com logo5 Breakout Stocks Under $10 Set to Soar (NASDAQ:ADMP)
www.thestreet.com - August 18 at 3:19 PM
4-traders.com logoAdamis Pharmaceuticals : reports 2Q loss (NASDAQ:ADMP)
www.4-traders.com - August 16 at 11:55 AM
sg.finance.yahoo.com logoAdamis reports 2Q loss (NASDAQ:ADMP)
sg.finance.yahoo.com - August 16 at 11:55 AM
biz.yahoo.com logoADAMIS PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:ADMP)
biz.yahoo.com - August 15 at 8:51 PM
streetinsider.com logoAdamis Pharmaceuticals (ADMP) Receives USPTO Notice of Allowance on Taper DPI-Related Patent (NASDAQ:ADMP)
www.streetinsider.com - August 4 at 11:50 AM
streetinsider.com logoAdamis Pharmaceuticals (ADMP) Receives USPTO Notice of Allowance on Taper DPI-Related Patent - StreetInsider.com (NASDAQ:ADMP)
www.streetinsider.com - August 3 at 11:52 AM
publicnow.com logoAdamis Pharmaceuticals Strengthens Patent Portfolio for its Dry Powder Inhaler (NASDAQ:ADMP)
www.publicnow.com - August 3 at 11:52 AM
4-traders.com logoAdamis Pharmaceuticals : Announces $11.1 Million Registered Direct Offering (NASDAQ:ADMP)
www.4-traders.com - July 30 at 3:24 PM
finance.yahoo.com logo8:45 am Adamis Pharma announces $11.1 mln registered direct offering at $3.095/unit (NASDAQ:ADMP)
finance.yahoo.com - July 30 at 8:45 AM
biz.yahoo.com logoADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S (NASDAQ:ADMP)
biz.yahoo.com - July 29 at 5:27 PM
streetinsider.com logoAdamis Pharmaceuticals (ADMP) Enters $11.1M Subscription Agreements Direct Offering (NASDAQ:ADMP)
www.streetinsider.com - July 29 at 12:18 PM
publicnow.com logoAdamis Pharmaceuticals Announces $11.1 Million Registered Direct Offering (NASDAQ:ADMP)
www.publicnow.com - July 29 at 9:08 AM
biz.yahoo.com logoADAMIS PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ADMP)
biz.yahoo.com - July 28 at 6:09 AM
breakingfinancenews.com logoMaxim Group recorded (NASDAQ:ADMP) Adamis Pharmaceuticals, scaling down its target price to $10 earlier today (NASDAQ:ADMP)
breakingfinancenews.com - July 22 at 8:18 PM
News IconChecking in on Stock Volatility for: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily (NASDAQ:ADMP)
www.engelwooddaily.com - July 22 at 11:29 AM
streetinsider.com logoAdamis Pharmaceuticals (ADMP) Says Allergan's (AGN) Watson Elected to Terminate Epinephrine PFS Agreement (NASDAQ:ADMP)
www.streetinsider.com - July 21 at 8:53 PM
News IconStock Moving Lower for the Month; Investor Update on Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily (NASDAQ:ADMP)
www.engelwooddaily.com - July 21 at 3:18 PM
streetinsider.com logoAdamis Pharmaceuticals (ADMP) Says Allergan's (AGN) Watson Elected to Terminate Epinephrine PFS Agreement - StreetInsider.com (NASDAQ:ADMP)
www.streetinsider.com - July 21 at 3:18 PM
seekingalpha.com logoAllergan backs out of deal with Adamis Pharma to commercialize Epinephrine Pre-Filled Syringe (NASDAQ:ADMP)
seekingalpha.com - July 21 at 11:48 AM
globenewswire.com logoAdamis Pharmaceuticals Provides Update On License Agreement with Allergan plc (NASDAQ:ADMP)
globenewswire.com - July 21 at 11:48 AM
news.cmlviz.com logoAdamis Pharmaceuticals Corporation Stock Momentum Hits Weakness - CML News (NASDAQ:ADMP)
news.cmlviz.com - July 16 at 11:42 AM
News IconEye on Stock Volatility for: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily (NASDAQ:ADMP)
www.engelwooddaily.com - July 14 at 12:11 PM
4-traders.com logoAdamis Pharmaceuticals : Announces Private Placement (NASDAQ:ADMP)
www.4-traders.com - July 13 at 8:52 PM
streetinsider.com logoAdamis Pharmaceuticals (ADMP) Announces 1.7M Share Private Placement of Convertible Preferred Stock - StreetInsider.com (NASDAQ:ADMP)
www.streetinsider.com - July 12 at 3:20 PM
News IconWhat Will Happen to Adamis Pharmaceuticals Corp Next? The Stock Just Declined A Lot - Press Telegraph (NASDAQ:ADMP)
presstelegraph.com - July 8 at 3:20 PM
News IconHeightened Volatility Check on: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) - Engelwood Daily (NASDAQ:ADMP)
www.engelwooddaily.com - July 8 at 3:20 PM

Social

Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff